Yufei Feng[Author] - Search Results

Year	Number of Results
2002	1
2004	1
2005	1
2012	4
2013	8
2014	3
2015	6
2017	1
2018	3
2019	4
2020	8
2021	16
2022	19
2023	21
2024	15
2025	10
2026	3

1

Irisin Protects Against Diabetic Cardiomyopathy by Suppressing Ferroptosis.

Ye H, Guo J, Wang X, Chen B, Hu L, Liu B, Song R, Feng Y, Zhang X. Ye H, et al. Among authors: feng y. Drug Dev Res. 2025 Jun;86(4):e70077. doi: 10.1002/ddr.70077. Drug Dev Res. 2025. PMID: 40455667

2

How to use macrophages to realise the treatment of tumour.

Zhang X, Li W, Sun J, Yang Z, Guan Q, Wang R, Li X, Li Y, Feng Y, Wang Y. Zhang X, et al. Among authors: feng y. J Drug Target. 2020 Dec;28(10):1034-1045. doi: 10.1080/1061186X.2020.1775236. Epub 2020 Jul 3. J Drug Target. 2020. PMID: 32603199 Review.

3

Advancements in hydrogel applications for osteoarthritis therapy.

Jing ZX, Lv Y, Wang YH, Feng YF. Jing ZX, et al. Nanomedicine (Lond). 2025 Aug;20(16):2093-2116. doi: 10.1080/17435889.2025.2535274. Epub 2025 Jul 28. Nanomedicine (Lond). 2025. PMID: 40719412 Review.

4

Analysis of murine B-cell epitopes on bluetongue virus 12 nonstructural protein 1.

HaiXiu W, EnCheng S, QingYuan X, Tao Y, Qin Z, YuFei F, JunPing L, Shuang L, Liang S, Jing S, DongLai W. HaiXiu W, et al. Among authors: yufei f. Appl Microbiol Biotechnol. 2015 Feb;99(3):1309-21. doi: 10.1007/s00253-014-6150-4. Epub 2014 Oct 26. Appl Microbiol Biotechnol. 2015. PMID: 25343975

5

Nano-Drug Delivery Systems Based on Natural Products.

Lv Y, Li W, Liao W, Jiang H, Liu Y, Cao J, Lu W, Feng Y. Lv Y, et al. Among authors: feng y. Int J Nanomedicine. 2024 Jan 18;19:541-569. doi: 10.2147/IJN.S443692. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38260243 Free PMC article. Review.

6

RALYL Overexpression Suppresses Colorectal Cancer via Modulating HNRNPC-Mediated MNK2 Alternative Splicing.

Ma Z, Zhu J, Chen M, Wu G, Liu X, Hu Z, Feng Y, Wang X, Liu F. Ma Z, et al. Among authors: feng y. Cancer Rep (Hoboken). 2025 Mar;8(3):e70179. doi: 10.1002/cnr2.70179. Cancer Rep (Hoboken). 2025. PMID: 40052233 Free PMC article.

7

rHuPH20-facilitated subcutaneous administration of monoclonal antibodies in cancer therapy.

Dong W, Chen M, Wang J, Xia L, Wang Q, Nie X, Feng Y, Fang Y. Dong W, et al. Among authors: feng y. Immunotherapy. 2021 Jan;13(1):79-88. doi: 10.2217/imt-2020-0204. Epub 2020 Nov 17. Immunotherapy. 2021. PMID: 33198539

8

N-methyl-N-nitrosourea induces zebrafish anomalous angiogenesis through Wnt/β-catenin pathway.

Fu S, Tan R, Feng Y, Yu P, Mo Y, Xiao W, Wang S, Zhang J. Fu S, et al. Among authors: feng y. Ecotoxicol Environ Saf. 2022 Jul 1;239:113674. doi: 10.1016/j.ecoenv.2022.113674. Epub 2022 May 25. Ecotoxicol Environ Saf. 2022. PMID: 35623148 Free article.

9

Population pharmacokinetic models of anti-PD-1 mAbs in patients with multiple tumor types: A systematic review.

Shang J, Huang L, Huang J, Ren X, Liu Y, Feng Y. Shang J, et al. Among authors: feng y. Front Immunol. 2022 Aug 2;13:871372. doi: 10.3389/fimmu.2022.871372. eCollection 2022. Front Immunol. 2022. PMID: 35983041 Free PMC article.

10

Lower circulating irisin levels in type 2 diabetes mellitus patients with chronic complications: A meta-analysis.

Hou Q, Song R, Zhao X, Yang C, Feng Y. Hou Q, et al. Among authors: feng y. Heliyon. 2023 Nov 4;9(11):e21859. doi: 10.1016/j.heliyon.2023.e21859. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027674 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year